Overview

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Status:
Completed
Trial end date:
2006-12-12
Target enrollment:
Participant gender:
Summary
Community based study assessing safety and efficacy of levetiracetam in partial onset seizures. The optimal dose in daily clinical practice will be used.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam